Merck's P/S multiple is roughly 4, and its P/FCF is 21. That makes its valuation a bit pricier than Pfizer's per dollar of revenue, but significantly cheaper per dollar of free cash flow. In other ...
WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say that's only a short-term solution to its ailing business.